Bank Of America Corp Akouos, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.16 $7,311 - $14,509	2,812 Added 39.67%	9,901 $68,000
Q2 2022 Aug 12, 2022	SELL	$2.46 - $5.2 $29,770 - $62,930	-12,102 Reduced 63.06%	7,089 $33,000
Q1 2022 May 16, 2022	SELL	$4.16 - $9.08 $35,780 - $78,097	-8,601 Reduced 30.95%	19,191 $91,000
Q4 2021 Feb 08, 2022	SELL	$7.65 - $11.38 $321,047 - $477,584	-41,967 Reduced 60.16%	27,792 $236,000
Q3 2021 Nov 15, 2021	BUY	$9.93 - $13.59 $331,612 - $453,838	33,395 Added 91.84%	69,759 $810,000

Q2 2021 Sep 13, 2021	BUY	$11.87 - $15.96 $431,640 - $580,369	36,364 New	36,364 $456,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.